The store will not work correctly when cookies are disabled.
(1R,4R,5R)-3-(4-Fluoro-phenyl)-1,4,5-trihydroxy-cyclohex-2-enecarboxylic acid
ID: ALA362122
PubChem CID: 6480941
Max Phase: Preclinical
Molecular Formula: C13H13FO5
Molecular Weight: 268.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)[C@]1(O)C=C(c2ccc(F)cc2)[C@@H](O)[C@H](O)C1
Standard InChI: InChI=1S/C13H13FO5/c14-8-3-1-7(2-4-8)9-5-13(19,12(17)18)6-10(15)11(9)16/h1-5,10-11,15-16,19H,6H2,(H,17,18)/t10-,11-,13+/m1/s1
Standard InChI Key: SYASNCLOYWGRTC-WZRBSPASSA-N
Molfile:
RDKit 2D
19 20 0 0 1 0 0 0 0 0999 V2000
5.3542 -1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3542 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0667 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0667 -1.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7792 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4750 0.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7792 -1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6417 -1.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0542 1.0958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 -1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6417 -2.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6500 0.3833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0667 -2.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3000 0.3958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4917 -1.9875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -2.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9375 -3.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -1.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5000 -3.2250 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 1 1 0
5 7 1 0
3 6 1 1
7 4 1 0
8 1 1 0
9 6 2 0
10 8 2 0
11 8 1 0
3 12 1 6
4 13 1 6
14 6 1 0
7 15 1 1
16 17 1 0
17 11 2 0
18 10 1 0
19 16 1 0
18 16 2 0
5 3 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.24 | Molecular Weight (Monoisotopic): 268.0747 | AlogP: 0.15 | #Rotatable Bonds: 2 |
Polar Surface Area: 97.99 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.42 | CX Basic pKa: ┄ | CX LogP: 0.06 | CX LogD: -3.34 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.61 | Np Likeness Score: 0.72 |
References
1. Sánchez-Sixto C, Prazeres VF, Castedo L, Lamb H, Hawkins AR, González-Bello C.. (2005) Structure-based design, synthesis, and biological evaluation of inhibitors of Mycobacterium tuberculosis type II dehydroquinase., 48 (15): [PMID:16033267] [10.1021/jm0501836] |